June 21, 2017
Related News
Other posts that you should not miss.
Positive early data from the BRIDGE1 study, a three-year 1000+ patient study in bronchiectasis funded by the …
June 3, 2019
ProAxsis CEO David Ribeiro was interviewed by ProActive Investors UK. Watch the video on Stock-Tube
May 4, 2016
ProAxsis Ltd today announces that the company has signed a partnership agreement to develop activity-based immunoassays for …
September 11, 2017
